The efficacy of CD34+ cells has also been investigated in the setting of neonatal brain injury, specifically using the MCAO model of stroke, and the Rice–Vannucci model of hypoxic-ischemic (HI) brain injury. This evidence concerns the gene CD34 and Stroke.